Skip to main content
Year archive

ADALTA LIMITED — 2022 filings

All 40 regulatory filings released by ADALTA LIMITED (1AD) in 2022, sourced directly from the official regulator.

40 Filings
2022 Period
2022 filings (40)
Filing Released Lang
Chair address and CEO presentation to AGM 35 pages 4.7MB
AGM Information
2022-11-21 English
Results of Meeting 3 pages 243.4KB
Declaration of Voting Results & Voting Rights Announcements
2022-11-21 English
AD-214 progress and priorities 5 pages 329.7KB
Capital/Financing Update
2022-11-01 English
AD-214 progress and priorities webinar presentation 22 pages 2.3MB
Investor Presentation
2022-11-01 English
Balance of R&D Tax Incentive Refund received 2 pages 273.7KB
Capital/Financing Update
2022-10-26 English
Quarterly Appendix 4C and Activities Report 10 pages 381.5KB
Interim / Quarterly Report
2022-10-25 English
Letter to Shareholders, Notice of AGM & Proxy Form 25 pages 766.1KB
AGM Information
2022-10-19 English
1AD & GPCR Therapeutics to evaluate CXCR4 i-bodies in cancer 4 pages 261.8KB
Capital/Financing Update
2022-10-12 English
Notification of cessation of securities - 1AD 4 pages 24.3KB
Regulatory Filings
2022-10-09 English
R&D Tax Incentive Refund received 2 pages 287.7KB
Capital/Financing Update
2022-10-03 English
Notification of Date of 2022 AGM 2 pages 254.5KB
AGM Information
2022-09-26 English
Preliminary Final Report 2 pages 227.1KB
Earnings Release
2022-08-28 English
Annual Report to shareholders 58 pages 1.7MB
Annual Report
2022-08-28 English
Appendix 4G and Corporate Governance Statement 30 pages 618.8KB
Regulatory Filings
2022-08-28 English
Sydney Investor Briefing Invitation 2 pages 210.9KB
Regulatory Filings
2022-08-07 English
Quarterly Appendix 4C and Activities Report 10 pages 446.6KB
Interim / Quarterly Report
2022-07-24 English
Company Presentation 23 pages 4.3MB
Investor Presentation
2022-07-24 English
Notification regarding unquoted securities - 1AD 6 pages 27.9KB
Share Issue/Capital Change
2022-07-05 English
Notification of cessation of securities - 1AD 4 pages 24.2KB
Regulatory Filings
2022-07-04 English
AD-214 program update, cash runway extension 4 pages 323.5KB
Capital/Financing Update
2022-07-03 English
European Patent for AD-214 granted 2 pages 297.6KB
Regulatory Filings
2022-06-13 English
BIO International Convention presentation 25 pages 4.3MB
Investor Presentation
2022-05-31 English
AdAlta presentation at Bioshares Biotech Summit 20 pages 3.5MB
Investor Presentation
2022-05-09 English
Indian patent for AD-214 2 pages 296.2KB
Regulatory Filings
2022-04-06 English
Notification of cessation of securities - 1AD 4 pages 24.1KB
Share Issue/Capital Change
2022-04-04 English
Notification regarding unquoted securities - 1AD 6 pages 27.8KB
Share Issue/Capital Change
2022-04-04 English
Quarterly Appendix 4C and Activities Report 11 pages 356.8KB
Interim / Quarterly Report
2022-04-04 English
PAC Partners Healthcare Conference - Corporate Presentation 67 pages 8.9MB
Investor Presentation
2022-04-04 English
Inhaled AD-214 preclinical program 4 pages 176.1KB
Regulatory Filings
2022-04-04 English
$1.6M Second Tranche R&D Cash Flow Loan Received 2 pages 113.1KB
Capital/Financing Update
2022-03-08 English
Chinese patent granted for AD-214 2 pages 300.4KB
Regulatory Filings
2022-03-01 English
Half Yearly Report and Accounts 22 pages 645.7KB
Interim / Quarterly Report
2022-02-22 English
Adjustment to Option Exercise Prices 2 pages 113.4KB
Capital/Financing Update
2022-02-15 English
Change in Director Interest Notice x 4 13 pages 380.8KB
Director's Dealing
2022-02-10 English
Application for quotation of securities - 1AD 6 pages 27.6KB
Share Issue/Capital Change
2022-02-06 English
Entitlement Offer Results 3 pages 312.3KB
Capital/Financing Update
2022-02-02 English
Quarterly Appendix 4C and Activities Report 11 pages 380.6KB
Interim / Quarterly Report
2022-01-23 English
Presentation to Share Cafe Webinar 16 pages 4.4MB
Investor Presentation
2022-01-19 English
Retraction of Slide in Presentations 2 pages 227.0KB
Regulatory Filings
2022-01-06 English
Presentation Conference Schedule - January 2022 26 pages 10.1MB
Investor Presentation
2022-01-03 English